¡Hola, Costa Rica! Efferon ya está aquí.

We are proud to announce that Efferon®LPS has received official authorization in Costa Rica, becoming the 41st country where next-generation extracorporeal therapy is available!

We are especially pleased to expand our collaboration with US Pharmacy Group, our trusted and highly respected partner across Latin America. With their extensive regional expertise, strong professional network, and deep understanding of local healthcare systems, we are confident that together we will successfully introduce this life-saving technology to healthcare professionals and patients throughout Costa Rica.

Efferon®LPS is a next-generation hemoadsorption device designed to remove both endotoxins and cytokines from the bloodstream. It has received EU approval for use in sepsis patients under the MDR.